Clinical Trials Browser

INDUSTRY × Hereditary Sensory and Autonomic Neuropathies × avelumab × Clear all

NCT03565991 2023-09-25

Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors

Phase 2 Terminated

202 enrolled 31 charts

Hereditary Sensory and Autonomic Neuropathies